IRIS
MONFORTE, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.200
EU - Europa 3.242
AS - Asia 1.546
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
OC - Oceania 1
Totale 9.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.177
IE - Irlanda 885
SE - Svezia 714
CN - Cina 570
UA - Ucraina 566
VN - Vietnam 507
SG - Singapore 399
DE - Germania 354
IT - Italia 221
FI - Finlandia 181
GB - Regno Unito 153
IN - India 47
RU - Federazione Russa 37
AT - Austria 33
FR - Francia 30
CZ - Repubblica Ceca 26
CA - Canada 22
BE - Belgio 18
IR - Iran 11
CH - Svizzera 4
PL - Polonia 4
RO - Romania 4
CL - Cile 3
EU - Europa 3
KR - Corea 3
NL - Olanda 3
TN - Tunisia 3
ZA - Sudafrica 3
KG - Kirghizistan 2
MA - Marocco 2
SA - Arabia Saudita 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
Totale 9.005
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.075
Dublin 885
Chandler 745
Dong Ket 507
Nyköping 482
Singapore 324
Beijing 247
Princeton 178
Ashburn 174
Cambridge 170
Medford 167
Dearborn 149
Des Moines 131
Boardman 113
Ann Arbor 86
Wilmington 60
Lancaster 49
Nanjing 40
Jinan 39
Woodbridge 39
San Mateo 38
Los Angeles 35
Vienna 33
Messina 32
Shenyang 32
Milan 27
Brno 26
Munich 23
Haikou 22
Hebei 21
Houston 19
Ningbo 19
Pune 18
Brussels 17
Zhengzhou 15
Norwalk 14
Tianjin 14
Guangzhou 13
New York 13
Ottawa 13
Taiyuan 12
Augusta 11
Ardabil 10
Catania 10
Fuzhou 10
Helsinki 10
Changsha 9
Hyderabad 9
London 9
Nanchang 9
Saint Petersburg 9
Seattle 9
Taizhou 9
Auburn Hills 8
Hangzhou 8
Monmouth Junction 8
Brooklyn 7
Hefei 7
Nicotera 7
Clearwater 6
Edinburgh 6
Mcallen 6
Nuremberg 6
Washington 6
Bangalore 5
Falls Church 5
Jiaxing 5
Mumbai 5
Riva 5
Xiangfen 5
Espoo 4
Frankfurt am Main 4
Kunming 4
Montréal 4
Nanning 4
Novokuznetsk 4
Toronto 4
West Jordan 4
Boston 3
Brugherio 3
Como 3
Durban 3
Francofonte 3
Las Vegas 3
Leawood 3
New Delhi 3
Santa Clara 3
Stockholm 3
Tunis 3
Bishkek 2
Bucharest 2
Carbonia 2
Changle 2
Chicago 2
Fiorenzuola D'arda 2
Florence 2
Guspini 2
Larne 2
Lublin 2
Manchester 2
Totale 6.422
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 201
1-[3,5-bis(trifluoromethyl)phenyl]-1H,3H-thiazolo[3,4- a]benzimidazole 156
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 155
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 151
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 147
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 145
1-Adamantanamine derivatives as potential anti-HIV agents 141
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 141
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 94
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 91
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 87
Graphene Quantum Dots Based Systems As HIV Inhibitors 80
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 79
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 78
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 76
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 74
Anti-HIV agents: design and discovery of new potent RT inhibitors 71
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 70
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 70
Annelated 1,5-benzothiazepines 67
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 66
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 65
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 65
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 64
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 64
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 64
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 64
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 63
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 62
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 60
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 60
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 60
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 60
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 59
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 59
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 59
Antiretroviral strategy using multi-target agents 59
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 58
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 57
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 57
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 57
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 56
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 56
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 56
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 56
TBZ-analoghi inibitori non nucleosidici della HIV-RT 56
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 56
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 55
Structure-activity relationship of anti-HIV thiazolo[3,4-a]benzimidazole derivatives 55
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 55
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 55
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 55
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 55
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 55
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 54
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 54
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 54
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 54
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 53
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 53
Pharmacophore-based design of HIV-1 integrase inhibitors 52
Synthesis and structural features of new cyclofunctionalized benzimidazoles 52
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 52
Pharmacophore Modeling, Docking Experiments And Discovery Of New Hiv-1 NNRTIs 52
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 52
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 52
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 51
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 51
Progettazione e Sintesi di Nuovi Inibitori dell'Integrasi dell'HIV-1 51
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 51
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 51
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 51
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 51
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 51
Anti-HIV agents: design and discovery of new potent RT inhibitors 50
Compounds with potential antitumor activity. VI - 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones. 50
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 50
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 50
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 50
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 50
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 49
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 49
Sintesi ed attività anti-HIV di derivati 4-tiazolidinonici. 48
SYNTHESIS AND ANTITUMOR-ACTIVITY EVALUATION OF 1- [(ARYLIDENE)AMINO]ADAMANTANES 48
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 47
Synthesis and biological activity of novel non-nucleoside HIV-1 RT inhibitors 47
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 47
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 47
Molecular Modeling, synthesis and SAR of anti-HIV agents 46
Synthesis, structural features and anti-HIV activity of TBZ analogues. 46
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 46
Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4- a]benzimidazoles 46
Ligand-based drug design and docking studies of HIV-1 non-nucleoside RT inhibitors 46
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 46
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent HIV-1 NNRTIs by molecular modeling studies 45
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 45
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 44
NNRTI TBZ analoghi: progettazione razionale, sintesi e SAR. 44
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 44
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 44
Totale 6.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020964 0 0 0 0 6 153 202 180 14 174 231 4
2020/20211.576 160 2 230 30 22 154 8 169 14 142 109 536
2021/20221.057 14 229 26 32 78 8 69 40 28 10 155 368
2022/20232.881 237 216 122 228 255 300 80 180 1.124 12 93 34
2023/2024545 58 101 41 93 52 84 1 23 2 29 12 49
2024/2025482 54 35 73 212 108 0 0 0 0 0 0 0
Totale 9.141